scispace - formally typeset
B

Bradley Nash

Researcher at Drexel University

Publications -  8
Citations -  100

Bradley Nash is an academic researcher from Drexel University. The author has contributed to research in topics: Chemokine receptor & Receptor. The author has an hindex of 4, co-authored 6 publications receiving 57 citations.

Papers
More filters
Book ChapterDOI

Functions of the chemokine receptor CXCR4 in the central nervous system and its regulation by μ-opioid receptors.

TL;DR: This chapter discusses chemokine-opioid interactions in neuronal and immune cells, focusing on their potential contribution to HIV-associated neurocognitive disorders.
Journal ArticleDOI

Mechanisms of neuronal dysfunction in HIV-associated neurocognitive disorders

Abstract: HIV-associated neurocognitive disorder (HAND) is characterized by cognitive and behavioral deficits in people living with HIV. HAND is still common in patients that take antiretroviral therapies, although they tend to present with less severe symptoms. The continued prevalence of HAND in treated patients is a major therapeutic challenge, as even minor cognitive impairment decreases patient’s quality of life. Therefore, modern HAND research aims to broaden our understanding of the mechanisms that drive cognitive impairment in people with HIV and identify promising molecular pathways and targets that could be exploited therapeutically. Recent studies suggest that HAND in treated patients is at least partially induced by subtle synaptodendritic damage and disruption of neuronal networks in brain areas that mediate learning, memory, and executive functions. Although the causes of subtle neuronal dysfunction are varied, reversing synaptodendritic damage in animal models restores cognitive function and thus highlights a promising therapeutic approach. In this review, we examine evidence of synaptodendritic damage and disrupted neuronal connectivity in HAND from clinical neuroimaging and neuropathology studies and discuss studies in HAND models that define structural and functional impairment of neurotransmission. Then, we report molecular pathways, mechanisms, and comorbidities involved in this neuronal dysfunction, discuss new approaches to reverse neuronal damage, and highlight current gaps in knowledge. Continued research on the manifestation and mechanisms of synaptic injury and network dysfunction in HAND patients and experimental models will be critical if we are to develop safe and effective therapies that reverse subtle neuropathology and cognitive impairment.
Journal ArticleDOI

Morphine-Induced Modulation of Endolysosomal Iron Mediates Upregulation of Ferritin Heavy Chain in Cortical Neurons.

TL;DR: It is demonstrated that iron mediates morphine-induced FHC upregulation and consequent dendritic spine deficits and implicate endolysosomal iron efflux to the cytoplasm in these effects.
Journal ArticleDOI

Opioid and chemokine regulation of cortical synaptodendritic damage in HIV-associated neurocognitive disorders.

TL;DR: Studies indicate that synaptodendritic damage and cognitive impairment in HAND may be reversible, and the prospects of using the CXCR4 signaling pathway to identify new approaches to reverse dendritic spine deficits are discussed.
Journal ArticleDOI

Molecular Features Contributing to Virus-Independent Intracellular Localization and Dynamic Behavior of the Herpesvirus Transport Protein US9

TL;DR: The results support the idea that, while US9 post-translational modification may be important to regulate cargo loading and, consequently, virion export and delivery, no additional viral functions are required for US9 role in intracellular transport.